Company Profile

Tri Harbor Holdings Corp., also known as Aceto, is a United States-based virtual manufacturer engaged in supplying specialty materials. The Company is primarily engaged in supplying its materials to life sciences and advanced technology end markets. The Company operates its business operations in nine countries, and distributes over 1,100 chemical compounds used principally by the pharmaceutical, nutraceutical, agricultural, and specialty chemical industries.

Employees

Sector

Pharmaceuticals

More about the company

07/10/24	Tri Harbor Holdings Corp. acquired Pharm-Rx Chemical Corporation.	CI
17/06/24	Actylis Announces Appointment of Scott Thomson as Chief Executive Officer	CI
25/03/24	Actylis and Novo Nordisk Pharmatech Announce a Strategic Partnership for the Distribution of Benzalkonium Chloride in Targeted European Countries	CI
22/09/23	Actylis Launches A New Cgmp Wfi Generation, Storage, and Distribution System with Additional Iso Class 7 Manufacturing Space	CI
28/02/23	Actylis Opens a 30,000Ft² cGMP Facility to Bolster its Innovative Api Manufacturing Capabilities	CI
02/03/22	Aceto Corporation acquired Talus Mineral Company and Biotron Laboratories, Inc.	CI
12/10/21	Aceto Corporation acquired A & C Bio Buffer Limited.	CI
02/06/21	Aceto Corporation acquired Cascade Chemistry.	CI
17/05/21	Aceto Corporation acquired an unknown majority stake in Finar Ltd.	CI
15/04/21	Aceto Strengthens Self-Manufacturing and Vaccine and Biopharmaceutical Offering with Acquisition of A&C	CI
15/04/21	Aceto Corporation acquired A&C.	CI
16/03/21	Aceto to Expand Bioreagent Offering to Support Growing Customer Demand in Biopharma and Cell Culture Manufacturing	CI
21/12/20	Aceto Corporation acquired IsleChem, LLC.	CI

Manager	Title	Age	Since
Scott Thomson CEO	Chief Executive Officer	-	17/06/2024
James Steele DFI	Director of Finance/CFO	-	-
Timothy Curl CTO	Chief Tech/Sci/R&D Officer	-	-

Director	Title	Age	Since
Salvatore Guccione BRD	Director/Board Member	63	-
Rakesh Sachdev CHM	Chairman	70	01/06/2019
Lori Koch BRD	Director/Board Member	51	01/12/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACETO CORPORATION	-36.82%	-63.46%	-	-	3.08M
ELI LILLY AND COMPANY	-1.21%	-3.04%	+39.94%	+145.38%	980B
JOHNSON & JOHNSON	-2.48%	-5.18%	+51.52%	+39.07%	550B
ABBVIE INC.	-2.14%	-4.94%	+16.71%	+56.15%	382B
ROCHE HOLDING AG	+0.25%	-3.09%	+23.00%	+15.81%	316B
ASTRAZENECA PLC	+0.61%	-1.69%	+25.42%	+13.64%	272B
NOVARTIS AG	+0.22%	-3.10%	+24.25%	+30.21%	268B
NOVO NORDISK A/S	+4.59%	+1.98%	-40.02%	-45.89%	199B
AMGEN INC.	-1.19%	-4.95%	+16.56%	+47.00%	182B
GILEAD SCIENCES, INC.	-1.35%	-1.46%	+14.59%	+56.94%	154B
Average	-3.95%	-3.02%	+19.11%	+39.81%	366.93B
Weighted average by Cap.	-0.78%	-3.68%	+27.80%	+63.70%

Aceto Corporation Stock Nasdaq

Stocks

US0044461004

Pharmaceuticals

Latest news : Aceto Corporation

Quotes and Performance

Managers and Directors: Aceto Corporation

Other Pharmaceuticals

Company Profile